Mark Pepys

From Wikipedia, the free encyclopedia

Sir Mark Pepys
Nationality	British
Fields	Amyloid and Amyloidosis
Institutions	University College London
Alma mater	University of Cambridge

Sir Mark Brian Pepys FRS was until 2011 Professor of Medicine at University College London and Head of Medicine at the Hampstead Campus and the Royal Free Hospital. He won the GlaxoSmithKline Prize in 2007 "for his excellent work as a clinical scientist who has identified specific proteins as new therapeutic targets and developed novel drugs with potential use in amyloidosis, Alzheimer's disease and cardiovascular disease". ^[1]

Mark Pepys finished his early education at the University of Cambridge, and then qualified as a medical doctor at University College London Medical School. He then returned to Cambridge to do a PhD in Immunology in 1973. In 1999 he became director of the University College London Centre for Amyloidosis and Acute Phase Proteins.

Mark Pepys has recently won the 2008 Ernst Chain Prize for his work on amyloid diseases, established by Imperial College London in recognition of leaders in their fields.

Pepys was knighted in the 2012 New Year Honours for services to biomedicine.^[2]

References

↑ "The Royal Society GlaxoSmithKline Prize and Lecture (1976) (2002)". royalsociety.org. Retrieved 2009-04-03.
↑ The London Gazette: (Supplement) no. 60009. p. 1. 31 December 2011.

Persondata
Name	Pepys, Mark
Alternative names
Short description	Head of Medicine at the Hampstead Campus and the Royal Free Hospital
Date of birth
Place of birth
Date of death
Place of death

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.